Lilly diabetes pill recommended for EU approval
Eli Lilly and Co. and Boehringer Ingelheim GmbH’s Trajenta medicine for Type 2 diabetes has been recommended for approval in Europe, putting the drug on track to enter the region’s market this year.
Health Care & Insurance
Articles
WellPoint goes online to educate about ER use
Health insurer WellPoint Inc. has enlisted Google Maps for new websites that help patients think twice before they visit an emergency room for care that a less-expensive retail health clinic could handle.
Tomisue Hilbert settles suit over $15M policy
Tomisue Hilbert quietly settled a 3-year-old lawsuit last month over whether a controversial life insurance policy issued in 2006 on her mother, Suzy Tomlinson, was valid, and whether the beneficiary of the policy, J.B. Carlson, committed fraud.
Lilly CEO: Immigration, tax laws slow innovation
The U.S. government needs to open its borders to attract and retain talented scientists for drugmakers to employ, Eli Lilly & Co. CEO John Lechleiter plans to tell a technology conference Thursday.
Report: State’s life science sector continues to grow
A total of 220 life sciences startups have been launched in Indiana since 2004, or an average of 44 per year, according to a new report from BioCrossroads that tracked the industry’s growth over the last eight years.
Groups call for probe of St. Francis hospital over charity care
Citizens Action Coalition Education Fund and Indiana Legal Services Inc. claim that “a good number” of Indianapolis south-side residents who should have qualified for reduced or waived bills at St. Francis were instead steered into payments plans.
Wishard to be renamed after $40M gift from developer
Wishard Health Services will change its name to Eskenazi Health after receiving a $40 million gift from Indianapolis real estate developer Sidney Eskenazi and his wife Lois, the county-owned hospital announced Wednesday morning.
Anthem settles suit involving 120K policyholders
Anthem Blue Cross, an affiliate of WellPoint Inc., has agreed to settle a lawsuit that accused the health insurer of manipulating policies and forcing patients into higher deductible policies with fewer benefits.
EU approves Lilly’s weekly diabetes drug Bydureon
European Union regulators have approved the first once-per-week diabetes medication, the companies that developed the drug said Tuesday.
Planned Parenthood stops seeing Medicaid patients
Planned Parenthood of Indiana is no longer seeing Medicaid patients because a federal judge hasn't ruled yet on its attempt to block a new Indiana law cutting funding for certain abortion providers, officials said Monday.
Survey: Hospitals still rewarding docs for volume
The latest physician recruitment survey from Texas-based Merritt Hawkins shows three-quarters of all physician searches include a performance bonus for the doctor. Fewer than 10 percent of those bonuses are tied to something other than volume of procedures.
Troubled economy fueling hospital deals
Battered by stagnant population growth and blue-collar job loss, Howard Regional Health is merging with Indiana University Health—a deal that reflects the challenges faced by hospitals in Indiana’s outlying cities.
State gets week to respond in Planned Parenthood case
A federal judge on Friday gave the state of Indiana a week to respond to the Obama administration's decision siding with Planned Parenthood of Indiana in an attempt to block the state's new abortion funding law.
Feds support Planned Parenthood in defunding case
The U.S. Justice Department entered the court battle over a tough new Indiana abortion law that disqualifies Planned Parenthood of Indiana from the Medicaid program, siding with the organization in its request Thursday for a court order blocking the statute as unconstitutional.
Community Health adopts low-cost mantra
Community Health Network has embarked on a strategy to become a low-cost, high-output machine in order to survive the coming harsh economic environment that an aging population and expanded health care coverage promises for hospitals.
IU Health strikes deal with Central Indiana Cancer Centers
Central Indiana Cancer Centers sold its five facilities to IU Health and transferred its 150 employees to the Indianapolis-based hospital system. The 16 physicians in the practice will remain independent, but they have signed a service agreement with IU Health that pulls the two entities into a tight embrace.
Analyst: Lilly drug poised for continued growth
Eli Lilly and Co.'s lung cancer treatment Alimta is poised for continued growth based on recently released study data, according to a new Credit Suisse analyst report.
Arguments filed in Planned Parenthood case
A federal judge received final arguments Tuesday in Planned Parenthood of Indiana's request to block a tough new abortion law that makes Indiana the first state disqualifying the organization from providing general health services under Medicaid and taking away $1.4 million of its public funding.
Carmel senior-living project to create 340 jobs
Carmel Mayor Jim Brainard on Tuesday unveiled details of a multimillion-dollar project expected to create more than 200 construction jobs and 140 permanent positions over the next two years.
Q&A
Vi Shukla is a scientific leader at Indianapolis-based Dow AgroSciences LLC, focused on its Exzact Precision Technology tools for genetic engineering of plants and crops. Dow Agro used the technology in its own crop seed products, and has also been licensing for use in tomatos and trees.